Bayesian Borrowing of External Information in Clinical Trials: A Comparison of MAP, RMAP, and SAM Priors
- 1Vanderbilt University Medical Center
Abstract
Bayesian borrowing of external information can improve trial efficiency, particularly in pediatric and rare disease settings where patient populations are limited, but may introduce bias and inflate the Type I error rate when the trial differs from external studies. Recent U.S. Food and Drug Administration (FDA) draft Bayesian guidance emphasizes careful evaluation of external information, prior specification, and assessment of operating characteristics.
This paper compares three meta-analytic-predictive (MAP)-based methods for Bayesian borrowing: the MAP prior, robust MAP (RMAP) prior, and self-adapting mixture (SAM) prior. An adaptive platform trial design in Rett syndrome is used as a case study. Simulation studies evaluate frequentist operating characteristics under varying prior-data conflict, between-study heterogeneity, treatment effects, and clinically significant differences (CSDs) for the SAM prior.
The MAP prior achieved the greatest efficiency when external and current data were compatible but exhibited the largest bias under substantial prior-data conflict. The RMAP priors improved robustness through fixed robust-component weights, whereas the SAM prior adaptively adjusted borrowing and was less sensitive to prior-data conflict while retaining efficiency gains when the data were compatible. Although the CSD influenced the degree of adaptive borrowing, as reflected by effective sample size, it had only a modest impact on frequentist operating characteristics. Sensitivity analyses using a skeptical robust component yielded similar qualitative conclusions, while accentuating the differences between the MAP and RMAP priors.
These findings provide guidance for evaluating and selecting MAP-based borrowing strategies before trial implementation, particularly in rare disease settings, consistent with current FDA recommendations.
Related
- Comparison of External Oblique Intercostal Plane Block and Subcostal Transversus Abdominis Plane Block for Postoperative Analgesia After Open Radical Gastrectomy: A Single-Blind Randomized Trial
- Filling the information gap: a validated comparison of ChatGPT, Gemini, and Claude for penile cancer patient education
- External Load During Warm-Up and Early-Match Running Performance of Starting and Substitute Football Players: A Within-Player Comparison.
- Medical Decision‐Making Capacity in Early‐Stage Alzheimer Patients: Comparison With Healthy Controls and Benefit of Assistive Information
- Perioperative Intravenous Antibiotic Regimens and Surgical Site Infection After Colorectal Surgery: Clinical Associations and External Evaluation of Risk Prediction Models
BibTeX
@misc{choi2026bayesian,
title = {{Bayesian Borrowing of External Information in Clinical Trials: A Comparison of MAP, RMAP, and SAM Priors}},
author = {L. Choi and E. McNeer and C. A. Beck and J. L. Neul},
howpublished = {medRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.26.26360843},
url = {https://www.medrxiv.org/content/10.64898/2026.08.26.26360843v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Bayesian Borrowing of External Information in Clinical Trials: A Comparison of MAP, RMAP, and SAM Priors
AU - L. Choi
AU - E. McNeer
AU - C. A. Beck
AU - J. L. Neul
PY - 2026
DA - 2026/08/26
PB - medRxiv
DO - 10.64898/2026.08.26.26360843
UR - https://www.medrxiv.org/content/10.64898/2026.08.26.26360843v1
AB - Bayesian borrowing of external information can improve trial efficiency, particularly in pediatric and rare disease settings where patient populations are limited, but may introduce bias and inflate the Type I error rate when the trial differs from external studies. Recent U.S. Food and Drug Administration (FDA) draft Bayesian guidance emphasizes careful evaluation of external information, prior specification, and assessment of operating characteristics. This paper compares three meta-analytic-predictive (MAP)-based methods for Bayesian borrowing: the MAP prior, robust MAP (RMAP) prior, and self-adapting mixture (SAM) prior. An adaptive platform trial design in Rett syndrome is used as a case study. Simulation studies evaluate frequentist operating characteristics under varying prior-data conflict, between-study heterogeneity, treatment effects, and clinically significant differences (CSDs) for the SAM prior. The MAP prior achieved the greatest efficiency when external and current data were compatible but exhibited the largest bias under substantial prior-data conflict. The RMAP priors improved robustness through fixed robust-component weights, whereas the SAM prior adaptively adjusted borrowing and was less sensitive to prior-data conflict while retaining efficiency gains when the data were compatible. Although the CSD influenced the degree of adaptive borrowing, as reflected by effective sample size, it had only a modest impact on frequentist operating characteristics. Sensitivity analyses using a skeptical robust component yielded similar qualitative conclusions, while accentuating the differences between the MAP and RMAP priors. These findings provide guidance for evaluating and selecting MAP-based borrowing strategies before trial implementation, particularly in rare disease settings, consistent with current FDA recommendations.
ER -